ENDO: Liraglutide May Benefit Adolescents With Obesity

WEDNESDAY, April 1, 2020 -- Liraglutide plus lifestyle therapy results in a significantly greater reduction in body mass index (BMI) standard-deviation score than placebo among adolescents with obesity, according to a study published online March 31...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news